Jennifer Kayden Lee, EVP, Head of North America at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 5,932 shares at $60.08 ($359K) on 2025-02-05, disclosed to the SEC on 2025-02-07.
Scheduled sale ($359k) by EVP, Head of North America under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.08 | 1,733 | $104K | 29.0% |
| 2 | $60.08 | 1,733 | $104K | 29.0% |
| 3 | $61.01 | 1,133 | $69K | 19.3% |
| 4 | $61.01 | 1,133 | $69K | 19.3% |
| 5 | $61.95 | 200 | $12K | 3.5% |
| Total | $60.50 avg | 5,932 |
| $359K |
| 100% |
| Filing → |
| RYTM | SELL | 2025-02-14 | $240K | — | Filing → |
| RYTM | SELL | 2025-02-11 | $611K | — | Filing → |
| RYTM | SELL | 2025-02-04 | $172K | — | Filing → |